Time to get in is now at $25.00 us
Cheapest big pharma in any market. Compare this to any name you want. The amount of cash flow it generates and the assets it has it trading for a huge discount. Yes debt concerns remain..but are way overblown. They got into that debt by buying salix and Bausch and both brands are doing much better under Valeant. I think if you give it 6 mths this will be trading at 50 $ us.. Looking forward to asset sales to reduce debts.